Is IBOC a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for International Bancshares Corporation (IBOC) rests on A funding base that is hard to replicate: Interest expense fell to ~$98.3 million in the first half of 2026 even as deposits grew to ~$12.7 billion, because a large share of that base is low-cost and non-interest-bearing, much of it from cross-border commercial customers along the Texas border. The bear case rests on the second-quarter jump in non-accrual loans, from ~$140.3 million to ~$297.1 million on what the company describes as a single affordable housing relationship, is the live question, and the ~$170.0 million allowance covers only part of it. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
International Bancshares Corporation is a multibank financial holding company headquartered in Laredo, Texas, operating through International Bank of Commerce and affiliated charters across roughly ~75 communities in Texas and Oklahoma. Founded in 1966 and still led by Dennis Nixon, it held about ~$17.0 billion in assets, ~$12.7 billion in deposits and ~$9.9 billion in gross loans at June 30, 2026, with roughly ~2,319 employees. Its distinguishing asset is geography. The branch network is concentrated on the US-Mexico border, where cross-border trade and deposits from Mexican businesses and individuals supply an unusually cheap and sticky funding base. Commercial and commercial real estate lending does most of the earning; treasury management, international services and deposit fees do the rest. The measures a bank is actually judged on read well. First-half 2026 net interest income was ~$336.7 million against ~$98.3 million of interest expense, non-interest income was ~$86.5 million, and non-interest expense of ~$158.7 million works out to an efficiency ratio near ~38%, a level most banks its size never reach. Return on assets of roughly ~2.4% is close to double the regional bank norm, yet the stock changes hands around ~11 times trailing earnings and ~1.5 times tangible book. The counterweight arrived in the second quarter. Non-accrual loans jumped from ~$140.3 million at year-end to ~$297.1 million, almost entirely one relationship of loans secured by interests in affordable housing projects, against an allowance for credit losses of ~$170.0 million. Management states that no losses have been realized on those loans and may never be. Whether that holds is the question the multiple is pricing.
The bull case for IBOC
1. A funding base that is hard to replicate
Interest expense fell to ~$98.3 million in the first half of 2026 even as deposits grew to ~$12.7 billion, because a large share of that base is low-cost and non-interest-bearing, much of it from cross-border commercial customers along the Texas border. Annualizing first-half net interest income of ~$336.7 million against earning assets implies a margin near ~4.3%, comfortably above the regional bank average. A lender in Dallas or Phoenix paying market rates for the same deposits earns materially less on an identical loan.
2. Costs that stay put
Non-interest expense of ~$158.7 million against ~$423.2 million of first-half revenue is an efficiency ratio near ~38%, which most banks under ~$25 billion in assets do not reach. About ~2,319 employees support ~$17.0 billion of assets, so each dollar of margin drops through at a high rate, and that is how a ~49% net margin and a ~2.4% return on assets show up at a plain community lender. Management has been explicit about process automation and AI tooling as the next cost lever.
3. Balance sheet growth restarted
Net loans grew from ~$9.3 billion at the end of 2025 to ~$9.7 billion at June 30, 2026, and deposits from ~$12.4 billion to ~$12.7 billion, after a stretch of flat lending. The loan-to-deposit ratio is still only about ~77%, leaving room to fund more credit without reaching for wholesale money. Growth of that shape adds to earnings without adding much to funding cost.
4. Capital accumulates rather than leaves
Shareholders' equity rose to ~$3.375 billion at mid-year from ~$3.252 billion at the end of 2025, and book value per share went from ~$44.96 at the end of 2024 to ~$54.28, with tangible book value per share around ~$49.70. The dividend was raised about ~4.3% to ~$0.73 per share paid semi-annually, roughly ~$1.46 a year, consuming only about a fifth of earnings. Buybacks have been essentially dormant, with only ~2,144 treasury shares purchased in the first half, so retained profit compounds into book value instead.
The bear case for IBOC
The second-quarter jump in non-accrual loans, from ~$140.3 million to ~$297.1 million on what the company describes as a single affordable housing relationship, is the live question, and the ~$170.0 million allowance covers only part of it. Concentration is structural, since the loan book and the deposit base both lean on Texas border markets whose economics move with US and Mexico trade policy, tariffs, and the peso. Lower short rates would ease funding costs, but the balance sheet is asset-sensitive, so a sustained cutting cycle compresses the ~4.3% margin that produces most of the earnings. The ~$5.1 billion available-for-sale securities book carried roughly ~$350 million of unrealized losses against ~$3.4 billion of equity at mid-year, which limits flexibility to reposition without crystallizing them. Separately, an ERISA class action over the employees' profit sharing plan is pending in Texas federal court after being revived on appeal, a matter distinct from securities-fraud litigation, of which none is filed against the company.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding IBOC already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on IBOC
Too few analysts publish on IBOC for a consensus target to mean anything, so there is no professional average to weigh against your own view. That cuts both ways: less informed opinion to lean on, and less of it already priced in. The IBOC forecast page covers what coverage does exist.
How is IBOC valued? (as of August 2026)
Snapshot for IBOC as of August 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$837.6M, net interest income plus fees
- Net income / diluted EPS (TTM): ~$413.3M and ~$6.64
- P/E and price to tangible book: ~11x and ~1.5x
- Return on assets / return on equity: ~2.4% and ~12.5%
- Efficiency ratio (H1 2026): ~38%
- Non-accrual loans: ~$297.1M, about ~3.0% of gross loans
The ~$837.6 million revenue line is net interest income plus fee income, not gross interest income, which is the reporting convention for banks: gross interest income alone ran ~$435.0 million in the first half of 2026. Profitability rather than growth is the story, with revenue moving from ~$798.9 million in 2023 to ~$827.1 million in 2025 while net income held near ~$410 million throughout, and the ~49% net margin is largely a function of that ~38% efficiency ratio. At roughly ~$73 a share and a ~$4.56 billion market cap, the market pays about ~11 times those earnings and ~1.5 times tangible book value of around ~$49.70 per share.
How do you decide if IBOC is a buy?
Rather than asking whether IBOC is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold IBOC indirectly through an index or sector ETF before adding more.
What would change your mind on IBOC
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: A funding base that is hard to replicate stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: the second-quarter jump in non-accrual loans, from ~$140.3 million to ~$297.1 million on what the company describes as a single affordable housing relationship, is the live question, and the ~$170.0 million allowance covers only part of it fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the IBOC stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about IBOC against your real portfolio and see your actual exposure before deciding.
Investing in International Bancshares Corporation with AI
Connect the broker you already use and ask Walnut's AI how IBOC fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is IBOC a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on A funding base that is hard to replicate, with revenue (ttm) at ~$837.6M, net interest income plus fees. The bear case rests on the second-quarter jump in non-accrual loans, from ~$140.3 million to ~$297.1 million on what the company describes as a single affordable housing relationship, is the live question, and the ~$170.0 million allowance covers only part of it. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell IBOC?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The second-quarter jump in non-accrual loans, from ~$140.3 million to ~$297.1 million on what the company describes as a single affordable housing relationship, is the live question, and the ~$170.0 million allowance covers only part of it. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.
What is the bull case for IBOC?
+
A funding base that is hard to replicate. Interest expense fell to ~$98.3 million in the first half of 2026 even as deposits grew to ~$12.7 billion, because a large share of that base is low-cost and non-interest-bearing, much of it from cross-border commercial customers along the Texas border.
What is the bear case for IBOC?
+
The second-quarter jump in non-accrual loans, from ~$140.3 million to ~$297.1 million on what the company describes as a single affordable housing relationship, is the live question, and the ~$170.0 million allowance covers only part of it. Concentration is structural, since the loan book and the deposit base both lean on Texas border markets whose economics move with US and Mexico trade policy, tariffs, and the peso. Lower short rates would ease funding costs, but the balance sheet is asset-sensitive, so a sustained cutting cycle compresses the ~4.3% margin that produces most of the earnings. The ~$5.1 billion available-for-sale securities book carried roughly ~$350 million of unrealized losses against ~$3.4 billion of equity at mid-year, which limits flexibility to reposition without crystallizing them. Separately, an ERISA class action over the employees' profit sharing plan is pending in Texas federal court after being revived on appeal, a matter distinct from securities-fraud litigation, of which none is filed against the company.
What would have to change for IBOC to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (A funding base that is hard to replicate) stalling in the reported numbers rather than in the narrative, the risk above (the second-quarter jump in non-accrual loans, from ~$140.3 million to ~$297.1 million on what the company describes as a single affordable housing relationship, is the live question, and the ~$170.0 million allowance covers only part of it) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
Why does IBOC trade at a lower multiple than its profitability suggests?
+
At roughly ~$73 a share and a ~$4.56 billion market cap, IBOC sits near ~11 times trailing earnings and about ~1.5 times tangible book value of roughly ~$49.70 per share. Banks earning a ~2.4% return on assets normally command more. Three things weigh on the multiple: heavy concentration in Texas border markets tied to Mexican trade, a long-tenured and closely held control structure that limits any takeover premium, and, since the second quarter of 2026, one very large non-accrual relationship.
What is IBOC's net interest margin, and why is it so high?
+
The company does not headline a margin figure, but annualizing first-half 2026 net interest income of ~$336.7 million against roughly ~$15.5 billion to ~$16 billion of earning assets implies a margin near ~4.3%, well above the regional bank average. Funding is the reason. A large portion of the ~$12.7 billion deposit base is low-cost and non-interest-bearing, much of it from cross-border commercial customers, and interest expense actually fell in the first half to ~$98.3 million as deposit rates eased.
Walnut is informational, not investment advice, and gives no verdict on IBOC. Analyst targets referenced here come from a August 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.